Funding Opportunity PAR-21-330 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.

Notice NOT-CA-21-115 from the NIH Guide for Grants and Contracts

Notice NOT-AT-21-018 from the NIH Guide for Grants and Contracts

Notice NOT-AT-21-017 from the NIH Guide for Grants and Contracts

Adapts bioinformatics tools, visualization packages, and annotation resources for research projects to independently and accurately perform research analysis.
From Medical College of Wisconsin - Wed, 08 Sep 2021 03:09:38 GMT - View all Milwaukee, WI jobs

Earned doctorate (or its foreign equivalent) or appropriate terminal degree. Experience in microbial ecology, molecular methods and/or bioinformatics to…
From Marquette University - Tue, 07 Sep 2021 22:22:56 GMT - View all Milwaukee, WI jobs

Every great life-changing discovery begins the same way—with new knowledge. It can change everything, from a single life to the future of entire communities.…
From Medical College of Wisconsin - Tue, 07 Sep 2021 21:11:30 GMT - View all Menomonee Falls, WI jobs

Position Summary: The Koch Lab in the Department of Plant Pathology is seeking a Research Scientist to support research efforts focusing on the microbiome of…
From University of Wisconsin–Madison - Tue, 07 Sep 2021 18:58:56 GMT - View all Madison, WI jobs

Notice NOT-NS-22-025 from the NIH Guide for Grants and Contracts

Notice NOT-NS-22-021 from the NIH Guide for Grants and Contracts

Notice NOT-HD-21-043 from the NIH Guide for Grants and Contracts

GBP50000.00 - GBP60000.00 per annum: SRG: Assay Development - NGS Oxfordshire, England

Notice NOT-OD-21-185 from the NIH Guide for Grants and Contracts

Notice NOT-NS-22-024 from the NIH Guide for Grants and Contracts

Cerevance offers a competitive salary and benefits package: Cerevance Ltd: About Cerevance: Cerevance is a neuroscience focused drug discovery company dedicated to finding innovative new medicines for debilitating CNS diso... Cambridge, Cambridgeshire (GB)

Competitive Salary: F. Hoffmann-La Roche AG: The Immunology Incubator is an innovative interface between Roche Pharma Research and Early Development (pRED) and the next generation of acade Switzerland (CH)

Competitive Salary: F. Hoffmann-La Roche AG: In Roche’s Pharmaceutical Research and Early Development organisation (pRED), we make transformative medicines for patients in order to tackle Switzerland (CH)

Funding Opportunity RFA-DK-21-026 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs). The DDRCCs are part of an integrated program of digestive and liver diseases research support provided by the NIDDK. The purpose of this Centers program is to bring together basic and clinical investigators as a means to enhance communication, collaboration, and effectiveness of ongoing research related to digestive and/or liver diseases within the NIDDK's mission. DDRCCs are based on the core concept, whereby shared resources aimed at fostering productivity, synergy, and new research ideas among the funded investigators are supported in a cost-effective manner. Each proposed DDRCC must be organized around a central theme that reflects the focus of the digestive or liver diseases research of the Center members. The central theme must be within the primary mission ofthe NIDDK, and not thematic areas for which other NIH Institutes or Centers are considered the primary source of NIH funding.

Funding Opportunity PAR-21-332 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk, and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter term outcomes such as weight loss and diabetes. The goal of this FOA is to support proof of concept studies for feasibility and exploratory development. Feasibility must not have already been developed in the literature or with preliminary data. While unpublished data are not permitted, references and data from widely available preprints that have a Digital Object Identifier (DOI) are acceptable. Investigators who have generated unpublished preliminary data should submit a proposal to companion R01.

Funding Opportunity PAR-21-331 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk, and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter-term outcomes such as weight loss and diabetes.